This article re-hashes much of the content of Ben Goldacre's book 'Bad Pharma', however it does not propose any solutions (Ben Goldacre does). There is plenty t

This article re-hashes much of the content of Ben Goldacre's book 'Bad Pharma', however it does not propose any solutions (Ben Goldacre does). There is plenty that can be done with legislation, as a customer of healthcare and in clinical trials. If all trials - good results or bad - were published then we would be half way there. http://www.badscience.net/2013/10/why-and-how-i-wrote-bad-pharma/ http://www.badscience.net/2013/10/why-and-how-i-wrote-bad-ph... The article mentions the company 'Amgen' and how they were not able to reproduce some earlier trial results. Alarm bells went off for me right there at the word 'Amgen'. They were the company that had the wonder drug EPO, as in of Lance Armstrong fame. That story is truly fascinating and best pieced together from the book 'Blood Medicine': http://www.bloodmedicine.info/ http://www.bloodmedicine.info/ ...and from the cycling scandal books that have came out recently, e.g. Tyler Hamilton's.